Losses for pharmaceutical sector

Lately most stocks of the pharmaceutical sector are under selling pressure. Over the past 3 months the sector is 6 percent lower. Investors who bought the average share of the sector in 2000 now have a stunning profit of around 1464 percent. Since 2012 the sector trades 216 percent higher. On average the sector yields a poor dividend yield of 0,5 percent.

Returns pharmaceutical sector

The American pharmaceutical companies are in terms of their price/earnings ratios cheaper than the European ones. Per US share investors pay now less the for the expected earnings per share. So it seems the markets expect less growth of them. The sector (Europe and US) now trades with a quite low CAPE-ratio of 8. Quidel Corp, Surmodics Inc are Repligen Corp are among the top CAPE-ratios. Vitamin Shoppe Inc, Teva Pharmaceuticals are GNC Holdings Inc among the ones with the lower CAPE-ratios.

The European pharmaceutical sector has a CAPE of 21 and the US's sector of . ,

Winners and losers pharmaceutical sector

The European stocks in this sector are around 21 percent higher and the US's are percent higher.

The European pharmaceutical companies now deliver more dividends then the US ones. These in Europe now yield 0,42 percent and these in US 0,07 percent. 0, 0 and 0 have now the highest dividend returns (in case the dividends per share are unchanged).

ValueSpectrum.com News Wire & Equity Research: +31 084-0032-842
news@valuespectrum.com

Copyright analist.nl B.V.
All rights reserved. Any redistribution, duplication or archiving prohibited. analist.nl doesn't warrant the accuracy of any News Content provided and shall not be liable for any errors, inaccuracies or for any actions taken in reliance thereon.